Safety of remote electrical neuromodulation for acute migraine treatment in pregnant women: A retrospective controlled survey-study

被引：5
|
作者：
Peretz, Addie [1 ]
Stark-Inbar, Alit [2 ]
Harris, Dagan [2 ]
Tamir, Shira [2 ]
Shmuely, Sharon [2 ]
Ironi, Alon [2 ]
Halpern, Audrey [3 ]
Chuang, Linus [4 ,5 ]
Riggins, Nina [6 ]
机构：
[1] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA
[2] Theran Bioelect LTD, Netanya, Israel
[3] Manhattan Ctr Headache & Neurol, New York, NY USA
[4] Nuvance Hlth, Dept Obstet & Gynecol, Danbury, CT USA
[5] Univ Vermont, Larners Coll Med, Burlington, VT USA
[6] Univ Calif San Diego, Dept Neurosci, San Diego, CA USA
来源：
HEADACHE | 2023年 / 63卷 / 07期
关键词：
gestational age; migraine; pregnancy; remote electrical neuromodulation; safety;
D O I：
10.1111/head.14586
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：968 / 970
页数：3
相关论文
共 50 条
  • [41] Rizatriptan (MAXALT) for the acute treatment of migraine and migraine recurrence. A placebo-controlled, outpatient study
    Teall, J
    Tuchman, M
    Cutler, N
    Gross, M
    Willoughby, E
    Smith, B
    Jiang, K
    Reines, S
    Block, G
    HEADACHE, 1998, 38 (04): : 281 - 287
  • [42] Kinetic Oscillation Stimulation as Treatment of Acute Migraine: A Randomized, Controlled Pilot Study
    Juto, Jan-Erik
    Hallin, Rolf G.
    HEADACHE, 2015, 55 (01): : 117 - 127
  • [43] Treatment of acute migraine by a partial rebreathing device: A randomized controlled pilot study
    Fuglsang, Cecilia H.
    Johansen, Troels
    Kaila, Kai
    Kasch, Helge
    Bach, Flemming W.
    CEPHALALGIA, 2018, 38 (10) : 1632 - 1643
  • [44] Pertussis Immunisation in Pregnancy Safety (PIPS) Study: A retrospective cohort study of safety outcomes in pregnant women vaccinated with Tdap vaccine
    Griffin, Jennifer B.
    Yu, Lennex
    Watson, Donna
    Turner, Nikki
    Walls, Tony
    Howe, Anna S.
    Jiang, Yannan
    Petousis-Harris, Helen
    VACCINE, 2018, 36 (34) : 5173 - 5179
  • [45] Acute Kidney Injury in Critically III Pregnant Women: A Retrospective Study on Risk Factors and Outcomes
    Song, Qifeng
    Jia, Jia
    Chen, Chen
    Li, Guofu
    IRANIAN JOURNAL OF KIDNEY DISEASES, 2024, 18 (04) : 195 - 203
  • [46] Phase 3 randomized, placebo-controlled, double-blind study of lasmiditan for acute treatment of migraine
    Goadsby, Peter J.
    Wietecha, Linda A.
    Dennehy, Ellen B.
    Kuca, Bernice
    Case, Michael G.
    Aurora, Sheena K.
    Gaul, Charly
    BRAIN, 2019, 142 : 1894 - 1904
  • [47] The influence of multimodal behavioral treatment on the consumption of acute migraine drugs: a randomized, controlled study
    Hedborg, Kerstin
    Muhr, Carin
    CEPHALALGIA, 2012, 32 (04) : 297 - 307
  • [48] Safety and tolerability of ubrogepant for the acute treatment of migraine in participants taking atogepant for the preventive treatment of episodic migraine: Results from the TANDEM study
    Ailani, Jessica
    Lipton, Richard B.
    Blumenfeld, Andrew M.
    Mechtler, Laszlo
    Klein, Brad C.
    He, Molly Yizeng
    Smith, Jonathan H.
    Trugman, Joel M.
    Ferreira, Rosa de Abreu
    Brand-Schieber, Elimor
    HEADACHE, 2024,
  • [49] Acute leukemias in pregnant women: Results of a retrospective study at a local tertiary-care hospital in Japan
    Kobayashi, Shuhei
    Biyajima, Kyoko
    Matsuzawa, Shuji
    Sakai, Kaoko
    Kawakami, Fumihiro
    Kawakami, Toru
    Nishina, Sayaka
    Sakai, Hitoshi
    Fuseya, Chiho
    Nakazawa, Hideyuki
    EJHAEM, 2023, 4 (02): : 393 - 400
  • [50] Efficacy and safety of fast dissolving rizatriptan tablets in acute migraine treatment: Results of a surveillance study
    Evers, S.
    NERVENHEILKUNDE, 2008, 27 (09) : 813 - 817
12345